A detailed history of Northwest & Ethical Investments L.P. transactions in Exact Sciences Corp stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 27,513 shares of EXAS stock, worth $1.26 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,513
Previous 28,870 4.7%
Holding current value
$1.26 Million
Previous $1.97 Billion 21.39%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$49.33 - $71.97 $66,940 - $97,663
-1,357 Reduced 4.7%
27,513 $1.55 Billion
Q3 2024

Nov 13, 2024

SELL
$42.43 - $70.83 $1.54 Million - $2.57 Million
-36,242 Reduced 55.66%
28,870 $1.97 Billion
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $2.69 Million - $4.84 Million
65,112 New
65,112 $2.75 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.